Drugs Made In America Acquisition II Corp.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMII and other ETFs, options, and stocks.

About DMII

Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. 

CEO
Lynn Darlene Stockwell
CEOLynn Darlene Stockwell
Employees
Employees
Headquarters
Fort Lauderdale, Florida
HeadquartersFort Lauderdale, Florida
Founded
Founded
Employees
Employees

DMII Key Statistics

Market cap
652.47M
Market cap652.47M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
155.98K
Average volume155.98K
High today
High today
Low today
Low today
Open price
$9.94
Open price$9.94
Volume
0.00
Volume0.00
52 Week high
$9.97
52 Week high$9.97
52 Week low
$9.86
52 Week low$9.86

Stock Snapshot

As of today, Drugs Made In America Acquisition II Corp.(DMII) shares are valued at $9.96. The company's market cap stands at 652.47M.

During the trading day, Drugs Made In America Acquisition II Corp.(DMII) stock saw an opening price of $9.94, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 155.98K.

Over the past 52 weeks, Drugs Made In America Acquisition II Corp.(DMII) stock has traded between a high of $9.97 and a low of $9.86.

Over the past 52 weeks, Drugs Made In America Acquisition II Corp.(DMII) stock has traded between a high of $9.97 and a low of $9.86.

People also own

Based on the portfolios of people who own DMII. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .